Recent

% | $
Quotes you view appear here for quick access.

Sunesis Pharmaceuticals, Inc. Message Board

guinnessinu 6 posts  |  Last Activity: Jun 4, 2015 8:24 AM Member since: Jun 10, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    OPK announcement

    by cdavis766 Jun 4, 2015 8:09 AM
    guinnessinu guinnessinu Jun 4, 2015 8:24 AM Flag

    BRLI 36.98 will be 52.98 after 2.75 shares of OPKO at 19.12/each.

  • Reply to

    OPK is TEVA 20 yrs from now

    by whoppo142002 Jun 4, 2015 8:12 AM
    guinnessinu guinnessinu Jun 4, 2015 8:20 AM Flag

    2.75 shares of OPKO at $19.12/

  • guinnessinu by guinnessinu Jun 2, 2015 5:34 PM Flag

    When are meteor results expected ?

  • Reply to

    TSA screeners fail 95%

    by guinnessinu Jun 1, 2015 8:18 PM
    guinnessinu guinnessinu Jun 1, 2015 11:03 PM Flag

    It would be good to get the PR soon stating the first TSA delivery

  • guinnessinu by guinnessinu Jun 1, 2015 8:18 PM Flag

    TSA screeners failed tests to detect explosives, weapons
    By Eric Bradner and Rene Marsh, CNN
    Updated 7:21 PM ET, Mon June 1, 2015
    | Video Source: CNN

    Washington (CNN)Airport screeners failed to detect explosives and weapons in nearly every test that an undercover Homeland Security team conducted at dozens of airports, according to an internal investigation.

    The Transportation Security Administration found that "red teams" with the Department of Homeland Security's Office of the Inspector General were able to get banned items through the screening process in 67 out of 70 tests -- 95% -- it conducted across the nation.

    The test results were first reported by ABC News, and government officials confirmed them to CNN.

  • Reply to

    OPKO Health Acquires EirGen Pharma

    by farryman008 May 5, 2015 11:10 AM
    guinnessinu guinnessinu May 5, 2015 11:33 AM Flag

    Pursuant to the Agreements, the Buyers purchased from the Sellers all of the issued and outstanding shares of EirGen for approximately $135 million in the aggregate. OPKO Ireland acquired a portion of the outstanding shares of EirGen for approximately $100 million in cash, and the Company acquired the remaining outstanding shares of EirGen for approximately $35 million in shares of the Company's common stock (the "Stock Consideration"). The Stock Consideration consisted of 2,420,487 of the Company's shares based on the average closing sales price per share of the Company's Common Stock as reported by the New York Stock Exchange for the ten trading days immediately preceding the execution date of Agreements, or $14.39 per share. Pursuant to the Agreements, a portion of the Stock Consideration is being held in a separate escrow account to secure the indemnification obligations

SNSS
3.23-0.02(-0.62%)Jul 2 4:00 PMEDT